Daniel G. Mariam

Array ( [id] => 3616253 [patent_doc_number] => 05614193 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-03-25 [patent_title] => 'Hantavirus vaccine' [patent_app_type] => 1 [patent_app_number] => 8/218943 [patent_app_country] => US [patent_app_date] => 1994-03-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 9641 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 94 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/614/05614193.pdf [firstpage_image] =>[orig_patent_app_number] => 218943 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3653832 [patent_doc_number] => 05626850 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-05-06 [patent_title] => 'Non-shedding live herpesvirus vaccine' [patent_app_type] => 1 [patent_app_number] => 8/211278 [patent_app_country] => US [patent_app_date] => 1994-03-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 7102 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/626/05626850.pdf [firstpage_image] =>[orig_patent_app_number] => 211278 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3543544 [patent_doc_number] => 05554538 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-09-10 [patent_title] => 'DNA sequences derived from papillomavirus HPV-33 genome' [patent_app_type] => 1 [patent_app_number] => 8/222569 [patent_app_country] => US [patent_app_date] => 1994-03-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 4 [patent_no_of_words] => 4856 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/554/05554538.pdf [firstpage_image] =>[orig_patent_app_number] => 222569 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3685406 [patent_doc_number] => 05643715 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-07-01 [patent_title] => 'Human papillomavirus type 52 DNA sequences and methods for employing the same' [patent_app_type] => 1 [patent_app_number] => 8/217015 [patent_app_country] => US [patent_app_date] => 1994-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 9025 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 79 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/643/05643715.pdf [firstpage_image] =>[orig_patent_app_number] => 217015 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3590816 [patent_doc_number] => 05521072 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-05-28 [patent_title] => 'Actinobacillus pleuropneumoniae transferrin binding proteins and uses thereof' [patent_app_type] => 1 [patent_app_number] => 8/217438 [patent_app_country] => US [patent_app_date] => 1994-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 26 [patent_no_of_words] => 16899 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 192 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/521/05521072.pdf [firstpage_image] =>[orig_patent_app_number] => 217438 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3597311 [patent_doc_number] => 05559008 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-09-24 [patent_title] => 'Leukotoxin gene from Pasteurella suis' [patent_app_type] => 1 [patent_app_number] => 8/215805 [patent_app_country] => US [patent_app_date] => 1994-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 12 [patent_no_of_words] => 11596 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/559/05559008.pdf [firstpage_image] =>[orig_patent_app_number] => 215805 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3862380 [patent_doc_number] => 05837261 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-11-17 [patent_title] => 'Viral vaccines' [patent_app_type] => 1 [patent_app_number] => 8/216260 [patent_app_country] => US [patent_app_date] => 1994-03-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 33 [patent_figures_cnt] => 41 [patent_no_of_words] => 13429 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 120 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/837/05837261.pdf [firstpage_image] =>[orig_patent_app_number] => 216260 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3495495 [patent_doc_number] => 05532154 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-07-02 [patent_title] => 'Mutated alpha virus' [patent_app_type] => 1 [patent_app_number] => 8/213860 [patent_app_country] => US [patent_app_date] => 1994-03-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 5901 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/532/05532154.pdf [firstpage_image] =>[orig_patent_app_number] => 213860 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3682955 [patent_doc_number] => 05662908 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-09-02 [patent_title] => 'Invasive microorganisms' [patent_app_type] => 1 [patent_app_number] => 8/216086 [patent_app_country] => US [patent_app_date] => 1994-03-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 24932 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/662/05662908.pdf [firstpage_image] =>[orig_patent_app_number] => 216086 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3648872 [patent_doc_number] => 05605823 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-02-25 [patent_title] => 'Bioconversions catalysed by the toluene monooxygenase of Pseudomonas mendocinaKR-1' [patent_app_type] => 1 [patent_app_number] => 8/210407 [patent_app_country] => US [patent_app_date] => 1994-03-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 14131 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/605/05605823.pdf [firstpage_image] =>[orig_patent_app_number] => 210407 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3600900 [patent_doc_number] => 05578473 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-11-26 [patent_title] => 'Recombinant negative strand RNA virus' [patent_app_type] => 1 [patent_app_number] => 8/209178 [patent_app_country] => US [patent_app_date] => 1994-03-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 31 [patent_no_of_words] => 25876 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 109 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/578/05578473.pdf [firstpage_image] =>[orig_patent_app_number] => 209178 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3821019 [patent_doc_number] => 05759552 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-06-02 [patent_title] => 'Marek\'s disease virus recombinant poxvirus vaccine' [patent_app_type] => 1 [patent_app_number] => 8/207792 [patent_app_country] => US [patent_app_date] => 1994-03-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 12734 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/759/05759552.pdf [firstpage_image] =>[orig_patent_app_number] => 207792 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3407556 [patent_doc_number] => 05460815 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-10-24 [patent_title] => 'Feline infectious peritonitis vaccine and method of preparation' [patent_app_type] => 1 [patent_app_number] => 8/206268 [patent_app_country] => US [patent_app_date] => 1994-03-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4117 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/460/05460815.pdf [firstpage_image] =>[orig_patent_app_number] => 206268 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3652960 [patent_doc_number] => 05658572 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-08-19 [patent_title] => 'Infectious bursal disease virus recombinant poxvirus vaccine' [patent_app_type] => 1 [patent_app_number] => 8/204729 [patent_app_country] => US [patent_app_date] => 1994-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 5833 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/658/05658572.pdf [firstpage_image] =>[orig_patent_app_number] => 204729 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3562369 [patent_doc_number] => 05482708 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-01-09 [patent_title] => 'Fusion protein from feline leukaemia virus GP70 as vaccine' [patent_app_type] => 1 [patent_app_number] => 8/175393 [patent_app_country] => US [patent_app_date] => 1994-02-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 3478 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/482/05482708.pdf [firstpage_image] =>[orig_patent_app_number] => 175393 [rel_patent_id] =>[rel_patent_doc_number] =>)